Skip to main content
. 2003 Mar 18;88(6):928–932. doi: 10.1038/sj.bjc.6600825

Table 6. Distribution of CYP3A4 and VDR TaqI genotype frequencies and incidence rate of PRCa in the cohort population.

  CYP3A4&VDR TaqI SNPs genotypes (%)
  A/G, G/G and TT Other
Benign prostatic hyperplasia patient who developed PRCa during follow-up 3 (14) 18 (86)
Person-years of follow-up 151 3107
Incidence rate of PRCa per 100 000 men-years 1987 579

Other=other combined genotypes.